PRESS ASSOCIATION: Targeting two faulty genes could be key in treating blood cancer – study

Press/Media: Research

Release date: 2/10/2019

Description

Targeting two faulty genes associated with a deadly form of blood cancer could help develop better treatments, scientists have said.

A new study, published in the journal Nature, suggests the mutated genes known as SRSF2 and IDH2 join forces to bring about acute myeloid leukaemia (AML) – an aggressive form of cancer in the white blood cells.

Media coverage

TitleTargeting two faulty genes could be key in treating blood cancer – study
Media name/outletPress Association
Media typeWeb
Country/TerritoryUnited Kingdom
Date2/10/19
DescriptionTargeting two faulty genes associated with a deadly form of blood cancer could help develop better treatments, scientists have said.

A new study, published in the journal Nature, suggests the mutated genes known as SRSF2 and IDH2 join forces to bring about acute myeloid leukaemia (AML) – an aggressive form of cancer in the white blood cells.
URLhttps://home.bt.com/news/science-news/targeting-two-faulty-genes-could-be-key-in-treating-blood-cancer-study-11364399534876
PersonsDaniel Wiseman